Hungarian Brain Research Program(2017-1.2.1-NKP-2017-00002)
Horizon 2020 Framework Programme(H2020 766124)
Immunological markers and related signaling molecules in the blood are altered in
schizophrenia mouse models, in acutely relapsed patients with schizophrenia, and in
persons at a clinically high risk for subsequently developing psychosis, highlighting
their potential as prognostic and theranostic biomarkers. Therefore, we herein aimed
to identify novel potential biomarkers in the serum that are associated with purinergic
signaling.
